Search Results 2341-2350 of 14776 for Venlafaxine

  1. A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor - Mayo Clinic

    About this study. This phase III trial compares memantine to usual treatment in treating patients with brain tumors that are newly diagnosed or has come ...

  2. Intense Pulsed Light (IPL) and Meibomian Gland Expression to Treat Ocular Rosacea Secondary to Inactive Chronic Ocular GVHD - Mayo Clinic

    Is Intense Pulsed Light (IPL) treatment and eyelid meibomian gland manual expression safe and effective for allogeneic stem cell transplant patients with ocular ...

  3. A Study to Evaluate the Effectiveness and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy - Mayo Clinic

    The purpose of this study is to evaluate vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy. Participation eligibility. Participant ...

  4. Pharmacogenomics and Post-Operative Nausea and Vomiting - Mayo Clinic

    The hypothesis is that using genotypic variation in CYP2D6 to select the appropriate 5HT3 serotonin receptor antagonist to treat PONV will decrease rates of ...

  5. Publications - Raul E. Espinosa, M.D. - Mayo Clinic

    Effects of tricuspid valve regurgitation on outcome in patients with cardiac resynchronization therapy. Am J Cardiol. 2015 Mar 15; 115(6):783-9. Epub 2015 Jan ...

  6. Science Saturday: Z-Endoxifen emerges as potential breast cancer treatment - Mayo Clinic News Network

    Z-endoxifen, a potent derivative of the drug tamoxifen, could be a new treatment for the most common form of breast cancer in women with metastatic disease.

  7. Lurbinectedin + Doxorubicin In Leiomyosarcoma - Mayo Clinic

    The purpose of this study is to determine the tolerability of lurbinectedin with doxorubicin in people with soft tissue sarcoma, and to determine which is more ...

  8. A Study to Evaluate the Safety and Effectiveness of DCR-PHXC to Treat Patients with Primary Hyperoxaluria Type 1 or 2 and Severe Renal Impairment - Mayo Clinic

    The purpose of this study is to evaluate DCR-PHXC in patients with primary hyperoxaluria type 1 (PH1) and severe renal impairment, with or without dialysis.

  9. Right Drug, Right Dose, Right Time – Using Genomic Data to Individualize Treatment - Mayo Clinic

    About this study. This research is being done to better understand how genetic information related to drug dosing and use can affect medical care of ...

  10. Patient Stories - F. David Fortuin, M.D. - Mayo Clinic

    Your gift holds great power – donate today! ... Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.